9am.health, a virtual diabetes clinic delivering personalized care for prediabetes, and type 2 diabetes patients, announced a $3.7 million Seed funding round.
Investors include Founders Fund, Define Ventures, Speedinvest, and iSeed Ventures.
Founded in 2021 by the management team behind mySugr, 9am.health is available directly to consumers through a monthly subscription and connects people with a care team of licensed providers, pharmacists, and diabetes education and care specialists.
The company offers virtual care for people living with prediabetes and type 2 diabetes. Its subscribers also get medications, access to at-home tests, and personalized treatment plans that come with online access to patient care advocates that can answer any patient need safely from their homes.
How it works
Consumers subscribe to 9am.health, fill out a brief medical questionnaire, then connect with a licensed medical provider to get prescriptions and medications. The company currently provides tailored medication management for prediabetes and type 2 diabetes, who also may have common comorbidities, like hypertension (high blood pressure) and hyperlipidemia (high cholesterol).
According to the company, subscribers can also optimize their care plan by adding at-home A1C and cholesterol testing for a small cost, including shipping and lab analysis. Currently, the company does not support injectable medications that some people living with type 2 diabetes need (e.g., insulin), but the company plans to add medications to its platform over time.
“With in-home healthcare more important than ever, 9am.health is addressing a massive need both traditional and virtual care providers have ignored,” said Scott Nolan, Partner at Founders Fund. “The 9am.health team is using its expertise and pharma relationships to improve the lives of consumers living with diabetes through comprehensive, dedicated, virtual care.”
9am.health is currently available in 33 states in the U.S. Subscriptions start at $25 per month, including the first medication prescription, home delivery, and unlimited support from the care team via chat. Each additional medication is $5, and at-home testing for A1C or lipid screening is available for $15 per month, including delivery and lab analysis.
The company plans to scale and expand its virtual diabetes care services and at-home diabetes and prediabetes screening program with the new investment.
Telehealth companies raised a record $5 billion in 1H 2021, a 150% increase year-over-year compared to $2 billion raised in 1H 2020, according to the recently released Mercom’s 1H 2021 Digital Health Funding and M&A Report.